The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 991-997

  Mitne, Somaia ^a,b   Teixeira, Sergio Henrique ^a   Schwartz, Michal ^c   Belkin, Michael ^d   Farah, Michel Eid ^a   de Moraes, Nilva S Bueno ^a   da Cruz Nóia, Luciana ^a   Paes, Ângela Tavares ^b   Lottenberg, Cláudio Luiz ^b   Paranhos Júnior, Augusto ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Diabetic retinopathy; Glatiramer acetate; Neuroprotection; Panretinal photocoagulation

Indexed keywords

GLATIRAMER; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE SEVERITY; DRUG EFFECT; ELECTRORETINOGRAPHY; EYE EXAMINATION; EYE PHOTOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; HEIDELBERG RETINAL TOMOGRAPHY; HUMAN; LASER COAGULATION; MALE; MATHEMATICAL MODEL; NEUROPROTECTION; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; RANDOMIZED CONTROLLED TRIAL; RETINA; RETINAL NERVE FIBER LAYER; SLIT LAMP; THICKNESS; TONOMETRY; VISUAL ACUITY; VISUAL FIELD;

EID: 79961212784     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S22964     Document Type: Article

References (30)

1. Singh R, Ramasamy K, Abraham C, Gupta V, Gupta A. Diabetic retinopathy: an update. Indian J Ophthalmol. 2008;56(3):178-188.
2. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology. 1981;88(7):583-600.
3. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology. 1991; 98(Suppl 5):741-756.
4. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98(Suppl 5):766-785.
5. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. 1985;103(12): 1796-1806.
6. Ben-Shlomo G, Belokopytov M, Rosner M, et al. Functional deficits resulting from laser-induced damage in the rat retina. Lasers Surg Med. 2006;38(7):689-694.
7. Dastgheib K, Bressler SB, Green WR. Clinicopathologic correlation of laser lesion expansion after treatment of choroidal neovascularization. Retina. 1993;13(4):345-352.
8. Brancato R, Pece A, Avanza P, Radrizzani E. Photocoagulation scar expansion after laser therapy for choroidal neovascularization in degenerative myopia. Retina. 1990;10(4):239-243.
9. Osborne NN, Chidlow G, Wood JP, Schmidt KG, Casson R, Melena J. Expectations in the treatment of retinal diseases: neuroprotection. Curr Eye Res. 2001;22(5):321-332.
10. Barkana Y, Belkin M. Neuroprotection in ophthalmology: a review. Brain Res Bull. 2004;62(6):447-453.
11. Schori H, Kipnis J, Yoles E, et al. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc Natl Acad Sci U S A. 2001;98(6):3398-3403.
12. Kipnis J, Yoles E, Porat Z, et al. T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci U S A. 2000;97(13):7446-7451.
13. Bakalash S, Shlomo GB, Aloni E, et al. T-cell-based vaccination for morphological and functional neuroprotection in a rat model of chronically elevated intraocular pressure. J Mol Med. 2005;83(11):904-916.
14. Kipnis J, Schwartz M. Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders. Trends Mol Med. 2002;8(7):319-323.
15. Butovsky O, Koronyo-Hamaoui M, Kunis G, et al. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc Natl Acad Sci U S A. 2006;103(31):11784-11789.
16. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8):663-694.
17. Lim MC, Tanimoto SA, Furlani BA, et al. Effect of diabetic retinopathy and panretinal photocoagulation on retinal nerve fiber layer and optic nerve appearance. Arch Ophthalmol. 2009;127(7):857-862.
18. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121-130.
19. Murdoch IE, Morris SS, Cousens SN. People and eyes: statistical approaches in ophthalmology. Br J Ophthalmol. 1998;82(8):971-973.
20. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med. 1999;5(1):49-55.
21. Yoles E, Hauben E, Palgi O, et al. Protective autoimmunity is a physiological response to CNS trauma. J Neurosci. 2001;21(11):3740-3748.
22. Hauben E, Butovsky O, Nevo U, et al. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci. 2000;20(17):6421-6430.
23. Kerschensteiner M, Gallmeier E, Behrens L, et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med. 1999;189(5):865-870.
24. Shechter R, London A, Varol C, et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 2009;6(7):e1000113.
25. Belokopytov M, Ben-Shlomo G, Rosner M, et al. Functional efficacy of glatiramer acetate treatment for laser-induced retinal damage in rats. Lasers Surg Med. 2008;40(3):196-201.
26. Shulman S, Belokopytov M, Dubinsky G, Belkin M, Rosner M. Ameliorative effect of PN-277 on laser-induced retinal damage. Graefes Arch Clin Exp Ophthalmol. 2009 Mar;247(3):343-348.
27. Landa G, Butovsky O, Shoshani J, Schwartz M, Pollack A. Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration. Curr Eye Res. 2008;33(11): 1011-1013.
28. Kim HY, Cho HK. Peripapillary retinal nerve fiber layer thickness change after panretinal photocoagulation in patients with diabetic retinopathy. Korean J Ophthalmol. 2009 Mar;23(1):23-26.
29. Muqit MM, Wakely L, Stanga PE, Henson DB, Ghanchi FD. Effects of conventional argon panretinal laser photocoagulation on retinal nerve fibre layer and driving visual fields in diabetic retinopathy. Eye (Lond). 2010;24(7):1136-1142.
30. Davis MD, Fisher MR, Gangnon RE, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci. 1998;39(2):233-252.